Published Randomized Comparative Data Demonstrate Superior Outcomes with Dayspring in Adults Aged 65 and Older and Patients with Phlebolymphedema

Data ReadoutpositiveDayspringPositive

AI Analysis

Summary

Koya Medical published randomized comparative data showing Dayspring demonstrates superior outcomes in lower-extremity lymphedema patients aged 65 and older and those with phlebolymphedema, extending head-to-head evidence across two clinically important patient populations.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Randomized comparative data demonstrate superior outcomes in adults aged 65 and older and patients with phlebolymphedema

Importance:6/10

Sentiment:

0.70

clinical datalymphedemavenous diseasehead-to-head comparison

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on July 23, 2026 10:00 AM

Read Original